Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,187
Closed -$4.64M 107
2026
Q1
$4.64M Buy
+13,187
New +$4.7M 1.29% 35
2024
Q4
Sell
-12,732
Closed -$4.1M 98
2024
Q3
$4.1M Buy
+12,732
New +$4.16M 1.51% 22
2023
Q3
Sell
-11,868
Closed -$2.63M 99
2023
Q2
$2.63M Buy
11,868
+8,064
+212% +$1.87M 1.4% 26
2023
Q1
$920K Buy
3,804
+331
+10% +$81.3K 0.51% 55
2022
Q4
$912K Buy
+3,473
New +$931K 0.54% 55
2020
Q4
Sell
-409
Closed -$104K 111
2020
Q3
$104K Buy
+409
New +$101K 0.07% 111

Other funds holding AMGN

BNC Wealth Management's AMGN Position: Q2 2026 in Review

BNC Wealth Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 13,187 shares — an estimated $4.64M sold.

BNC Wealth Management first reported a position in AMGN in Q3 2020 and held it in 6 quarters. The position peaked at $4.64M in Q1 2026. 1,319 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BNC Wealth Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • BNC Wealth Management sold 13,187 Amgen shares in Q2 2026, an estimated $4.64M.
  • BNC Wealth Management first reported a position in Amgen in Q3 2020 and held it in 6 quarters.
  • BNC Wealth Management's Amgen position peaked at $4.64M in Q1 2026.
  • 1,319 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BNC Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.